PAEDIATRIC PHARMACOLOGY

 

DR SIMON ATTARD MONTALTO

 

 

General Principles

 

Variable issues in children:

access and delivery

absorption

volume of distribution

metabolism

clearance

 

These impact on:

efficacy

toxicity, side effects

interactions

 

Other issues:

licensing

research studies/data

costs

 

Influence of age

 

GI absorption: gastric pH rapidly after birth, slowly later

gastric emptying irregular

GI motility variable, steadies with age

GI motility affected by type/volume feed

GI flora

Enzyme activity:pancreatic increases with age

gall bladder activity/contraction

hepatic enzyme efficiency

GI flora

 

Administration

 

oral route:

liquid better than tablets

palatability & compliance

bioavailability

 

i.v. route:

problems with access

infusion or bolus (volume, rate, flush)

dead space, bore of cannulae

‘piggy-backing’, infusion drug interactions

infection risk,

extravasation

bioavailability depends on perfusion

 

i.m. route:

pain

bioavailability unreliable

 

skin:

large surface area (X3)

absorption of toxins

bioavailability dependent on hydration

 

lungs:

few agents

ideal when possible

local irritation/bleeding/flooding

 

Drug distribution

 

Depends on:

volume of distribution

binding to plasma proteins (e.g albumin)

 

Drug metabolism

 

Depends on:

liver function

also renal, intestine, lung, adrenal, skin function

affects dosage calculation with age

 

Drug excretion

 

Depends on:

renal tubular and glomerular function

e.g GFR slow <34wks; 2-4ml/min at birth; 8-20ml/min by 3 days; gradually increases to adult value by 5 months

 

Pharmokinetics

‘time course of drug in the body’

most linear kinetics

some saturation (zero order) kinetics, e.g phenytoin, salicylates, alcohol

 

Drug pharmokinetics is a factor of the following:

bioavailability

absorption

volume of distribution

elimination (t1/2)

clearance (total Cl depends on Clrenal, Clhepatic, etc)

perfusion, blood flow

 

Drug prescribing in children

Individualisation

great variability despite standardisation

genetic factors, intercurrent pathology

 

Target levels:

problematic in children

use only as guide

balance clinical effect against toxicity

drugs with clear response/toxicity ratio timing of sampling may be crucial

 

SAFE PRESCRIBING AT ALL TIMES

 

1.       aware of indications, efficacy, side effects

2.       aware of drug interactions

3.       prescibe by weight, age, surface area - no guesstimates

4.       write/prescribe clearly (legally inexcusable)

5.       consult if in doubt

6.       safe practice: check 5Ds: drug, dose, dilution, date, dual

7.       aware of costs/accountability (generics vs parent drug)